Recent advances in Clostridium difficile-associated disease
Authors:
- 1 March 2009
- journal article
- review article
- Published by Oxford University Press (OUP) in Postgraduate Medical Journal
- Vol. 85 (1001) , 152-162
Abstract
The main purpose of this article is to review recent developments in the management of acute and recurrent Clostridium difficile-associated disease, with consideration of existing and new antibiotic and non-antibiotic agents for treatment. Details of the current developmental stage of new agents are provided and the role of surgery in the management of severe disease is discussed. Infection control measures considered comprise prudent use of antimicrobials, prevention of cross-infection and surveillance. Other topics that are covered include the recent emergence of an epidemic hypervirulent strain, pathogenesis, clinical presentation and approaches to rapid diagnosis and assessment of the colonic disease.Keywords
This publication has 129 references indexed in Scilit:
- Vegetative Clostridium difficile Survives in Room Air on Moist Surfaces and in Gastric Contents with Reduced Acidity: a Potential Mechanism To Explain the Association between Proton Pump Inhibitors and C. difficile -Associated Diarrhea?Antimicrobial Agents and Chemotherapy, 2007
- In Vitro Activities of 15 Antimicrobial Agents against 110 Toxigenic Clostridium difficile Clinical Isolates Collected from 1983 to 2004Antimicrobial Agents and Chemotherapy, 2007
- Use of probiotic Lactobacillus preparation to prevent diarrhoea associated with antibiotics: randomised double blind placebo controlled trialBMJ, 2007
- Interruption of Recurrent Clostridium difficile-Associated Diarrhea Episodes by Serial Therapy with Vancomycin and RifaximinClinical Infectious Diseases, 2007
- Impact of Emergency Colectomy on Survival of Patients With Fulminant Clostridium difficile Colitis During an Epidemic Caused by a Hypervirulent StrainAnnals of Surgery, 2007
- Klebsiella oxytocaas a Causative Organism of Antibiotic-Associated Hemorrhagic ColitisNew England Journal of Medicine, 2006
- Human Monoclonal Antibodies Directed against Toxins A and B Prevent Clostridium difficile -Induced Mortality in HamstersInfection and Immunity, 2006
- Clostridium difficileToxins: Mechanism of Action and Role in DiseaseClinical Microbiology Reviews, 2005
- Randomised controlled trial of vancomycin for pseudomembranous colitis and postoperative diarrhoea.BMJ, 1978
- Antibiotic-Associated Pseudomembranous Colitis Due to Toxin-Producing ClostridiaNew England Journal of Medicine, 1978